Literature DB >> 18473239

Hb Agrinio [alpha29(B10)Le-->uPro (alpha2)] in combination with --(MED I). Results in a severe form of Hb H disease.

Xenia Felekis1, Marios Phylactides, Anthi Drousiotou, Sotiroulla Christou, Andreani Kyrri, Kyriakos Kyriakou, Eleni Kalogerou, George Christopoulos, Marina Kleanthous.   

Abstract

We report two cases of compound heterozygote patients for the --(MED I) and Hb Agrinio [alpha29(B10)Le-->uPro (alpha2)] anomalies in two unrelated Greek Cypriot families. The first patient had a serious form of Hb H disease and died at the age of 21 due to complications arising during an operation. The second patient showed a severe hematological picture and has been regularly transfused since an early age. This patient exhibits bone abnormalities as well as hepatosplenomegaly. The severity of these two incidences emphasizes the need for the inclusion of a screening test for the --(MED I)/alpha(Agrinio)alpha genotype among those already offered during prenatal diagnosis. Two homozygotes, as well as a number of simple, compound, and double heterozygotes for Hb Agrinio have been identified in Cyprus and their hematological indices are presented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18473239     DOI: 10.1080/03630260802004103

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  2 in total

1.  A precision medicine approach to a patient with unresolved pain following orthopedic surgery: a case report.

Authors:  David Gazzaniga; Ashley Brenton; Brian Meshkin
Journal:  J Med Case Rep       Date:  2017-02-24

2.  The molecular spectrum and distribution of haemoglobinopathies in Cyprus: a 20-year retrospective study.

Authors:  Petros Kountouris; Ioanna Kousiappa; Thessalia Papasavva; George Christopoulos; Eleni Pavlou; Miranda Petrou; Xenia Feleki; Eleni Karitzie; Marios Phylactides; Pavlos Fanis; Carsten W Lederer; Andreani R Kyrri; Eleni Kalogerou; Christiana Makariou; Christiana Ioannou; Loukas Kythreotis; Georgia Hadjilambi; Nicoletta Andreou; Evangelia Pangalou; Irene Savvidou; Michael Angastiniotis; Michael Hadjigavriel; Maria Sitarou; Annita Kolnagou; Marina Kleanthous; Soteroula Christou
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.